Cargando…
Acute pediatric hyperammonemia: current diagnosis and management strategies
Acute hyperammonemia may induce a neurologic impairment leading to an acute life-threatening condition. Coma duration, ammonia peak level, and hyperammonemia duration are the main risk factors of hyperammonemia-related neurologic deficits and death. In children, hyperammonemia is mainly caused by se...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140721/ https://www.ncbi.nlm.nih.gov/pubmed/30254497 http://dx.doi.org/10.2147/HMER.S140711 |
_version_ | 1783355615808061440 |
---|---|
author | Savy, Nadia Brossier, David Brunel-Guitton, Catherine Ducharme-Crevier, Laurence Du Pont-Thibodeau, Geneviève Jouvet, Philippe |
author_facet | Savy, Nadia Brossier, David Brunel-Guitton, Catherine Ducharme-Crevier, Laurence Du Pont-Thibodeau, Geneviève Jouvet, Philippe |
author_sort | Savy, Nadia |
collection | PubMed |
description | Acute hyperammonemia may induce a neurologic impairment leading to an acute life-threatening condition. Coma duration, ammonia peak level, and hyperammonemia duration are the main risk factors of hyperammonemia-related neurologic deficits and death. In children, hyperammonemia is mainly caused by severe liver failure and inborn errors of metabolism. In an acute setting, obtaining reliable plasma ammonia levels can be challenging because of the preanalytical difficulties that need to be addressed carefully. The management of hyperammonemia includes 1) identification of precipitating factors and cerebral edema presence, 2) a decrease in ammonia production by reducing protein intake and reversing catabolism, and 3) ammonia removal with pharmacologic treatment and, in the most severe cases, with extracorporeal therapies. In case of severe coma, transcranial Doppler ultrasound could be the method of choice to noninvasively monitor cerebral blood flow and titrate therapies. |
format | Online Article Text |
id | pubmed-6140721 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-61407212018-09-25 Acute pediatric hyperammonemia: current diagnosis and management strategies Savy, Nadia Brossier, David Brunel-Guitton, Catherine Ducharme-Crevier, Laurence Du Pont-Thibodeau, Geneviève Jouvet, Philippe Hepat Med Review Acute hyperammonemia may induce a neurologic impairment leading to an acute life-threatening condition. Coma duration, ammonia peak level, and hyperammonemia duration are the main risk factors of hyperammonemia-related neurologic deficits and death. In children, hyperammonemia is mainly caused by severe liver failure and inborn errors of metabolism. In an acute setting, obtaining reliable plasma ammonia levels can be challenging because of the preanalytical difficulties that need to be addressed carefully. The management of hyperammonemia includes 1) identification of precipitating factors and cerebral edema presence, 2) a decrease in ammonia production by reducing protein intake and reversing catabolism, and 3) ammonia removal with pharmacologic treatment and, in the most severe cases, with extracorporeal therapies. In case of severe coma, transcranial Doppler ultrasound could be the method of choice to noninvasively monitor cerebral blood flow and titrate therapies. Dove Medical Press 2018-09-12 /pmc/articles/PMC6140721/ /pubmed/30254497 http://dx.doi.org/10.2147/HMER.S140711 Text en © 2018 Savy et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Savy, Nadia Brossier, David Brunel-Guitton, Catherine Ducharme-Crevier, Laurence Du Pont-Thibodeau, Geneviève Jouvet, Philippe Acute pediatric hyperammonemia: current diagnosis and management strategies |
title | Acute pediatric hyperammonemia: current diagnosis and management strategies |
title_full | Acute pediatric hyperammonemia: current diagnosis and management strategies |
title_fullStr | Acute pediatric hyperammonemia: current diagnosis and management strategies |
title_full_unstemmed | Acute pediatric hyperammonemia: current diagnosis and management strategies |
title_short | Acute pediatric hyperammonemia: current diagnosis and management strategies |
title_sort | acute pediatric hyperammonemia: current diagnosis and management strategies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140721/ https://www.ncbi.nlm.nih.gov/pubmed/30254497 http://dx.doi.org/10.2147/HMER.S140711 |
work_keys_str_mv | AT savynadia acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies AT brossierdavid acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies AT brunelguittoncatherine acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies AT ducharmecrevierlaurence acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies AT dupontthibodeaugenevieve acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies AT jouvetphilippe acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies |